Business
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
PRINCETON, N.J., May 20, 2026--Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across...
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1497,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/8b31d7e540da369aea86f0562cb518ab"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FDIQ4vrBwADBefVC0KbVbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMg--/https://media.zenfs.com/en/business-wire.com/8b31d7e540da369aea86f0562cb518ab","width":960,"height":132},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/VrpgUIMisPrMnQRF1MHx9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTg4/https://media.zenfs.com/en/business-wire.com/8b31d7e540da369aea86f0562cb518ab","width":640,"height":88},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/GR93QU6Z5MvS3Nw_xazJEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMzA-/https://media.zenfs.com/en/business-wire.com/8b31d7e540da369aea86f0562cb518ab","width":1200,"height":165}},"lazy":false},{"type":"text","content":"The collaboration brings together BMS’ deep scientific expertise and Anthropic's frontier AI to accelerate the discovery, development and delivery of transformational medicines","length":180,"tagName":"p","attribs":{}},{"type":"text","content":"BMS will deploy Claude's agentic capabilities, moving beyond conversational AI, to connect its people, systems and institutional knowledge at enterprise scale","length":162,"tagName":"p","attribs":{}},{"type":"text","content":"PRINCETON, N.J., May 20, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY, "BMS"), a global biopharmaceutical leader, today announced a strategic agreement with Anthropic to deploy Claude across the company's research, clinical development, manufacturing, commercial, and corporate functions. The collaboration signals a meaningful evolution in how BMS deploys AI, moving beyond conversational tools that have defined the first wave of enterprise adoption, toward agentic capabilities built into the day-to-day workflows and systems that underpin its science and global operations.","length":600,"tagName":"p"},{"type":"text","content":"BMS will deploy Claude broadly across the company, empowering more than 30,000 employees with advanced reasoning and agentic capabilities. The deployment focuses on three priorities where BMS expects the highest near-term impact:","length":229,"tagName":"p"},{"type":"list","items":[{"val":...